Suchergebnisse - (Subject:"antiviral")

PubPharm (654)

1

Molnupiravir versus favipiravir in at-risk outpatients with COVID-19 : A randomized controlled trial in Thailand

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Salvadori, N. | Jourdain, G. | Krittayaphong, R. | +24

2

Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza : A Post Hoc Analysis of the BLOCKSTONE Trial

enthalten in: Influenza and other respiratory viruses | 2024

von Ikematsu, H. | Baba, T. | Saito, M. | +6

3

Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine : A Randomized Trial

enthalten in: JAMA | 2024

von Talal, A. | Markatou, M. | Liu, A. | +4

4

VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19

enthalten in: The New England journal of medicine | 2023

von Cao, Z. | Gao, W. | Bao, H. | +19

CommentIn: N Engl J Med. 2023 Jun 22;388(25):2395. - PMID 37342930

5

Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19 : A randomized double‑blind placebo‑controlled trial

enthalten in: International journal of molecular medicine | 2022

von Guzman-Esquivel, J. | Galvan-Salazar, H. | Guzman-Solorzano, H. | +17

6

Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients

enthalten in: Clinical pharmacology and therapeutics | 2022

von Prohn, M. | Cho, C. | Viberg, A. | +9

7

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19

enthalten in: Diabetes & metabolic syndrome | 2022

von Singh, A. | Singh, A. | Singh, R. | +1

8

Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients

enthalten in: Journal of medical virology | 2021

von Kalantari, S. | Fard, S. | Maleki, D. | +4

9

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C : The PRIORITIZE Study

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Sulkowski, M. | Moon, J. | Sherman, K. | +25

10

Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9

enthalten in: Scientific reports | 2021

von Lerum, T. | Maltzahn, N. | Aukrust, P. | +74

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[66]